Nanoparticle that delivers TLR7 ligand to tumor-draining lymph nodes can induce a local cytotoxic T cell response [121], leading to the proliferation of tumor antigen-specific CD8+ T cells and potent activation of DCs in the sentinel lymph nodes [89, 122]. The gene discussed is TLR7; the disease is neoplasm.